Developing and applying state-of-the-art mass spectrometry based molecular imaging approaches for nanomedicine and biomedical research, including mass spectrometry as a diagnostic and prognostic tool for personalized medicine in oncology, neurology and cardiovascular medicine.
From November 13-17th, 2017 M4i organised its first workshop dedicated to Mass Spectrometry Imaging (MSI).
Three PhD students from Maastricht University's M4I took the lead in bringing the fifth edition of the OurCon mass spectrometry imaging (MSI) to the Netherlands.
Research into the influence of lipids on the severity of a bacterial infection in a mammalian host published in PNAS.
The M4I Division of Imaging Mass Spectrometry is one of the world leaders in high resolution molecular imaging of biological surfaces. The division targets the development and application of state-of-the-art mass spectrometry based molecular imaging approaches for biomedical cellular and tissue research. Main research aim for the coming years is to develop and apply mass spectrometry as a diagnostic and prognostic tool for personalized medicine.
The New Dawn of Cancer Surgery |
Ron Heeren | TEDxMaastricht Nov 3, 2016
Pioneer prof. dr. Ron Heeren, University professor at Maastricht University and key player in the Top Research Institute M4I (Maastricht MultiModal Molecular Imaging Institute) is at the forefront of technological breakthroughs in oncology, neurology and cardiovascular medicine. Heeren’s team is developing biomedical applications of Mass Spectroscopy Imaging (MSI), or in other words techniques to photograph molecules.
“To try to understand biomolecules is to try to understand the complexity of life. It’s a puzzle that makes putting a radio together pale in comparison.”
“Imaging mass spectrometry produces huge and complex amount of data; giving sense to that data is what drives me.”